[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 5 - The Spring Supplement of Shefaye Khatam 2 - ::
Shefaye Khatam 2017, 5 - The Spring Supplement of Shefaye Khatam 2 -: 148-148 Back to browse issues page
P 117: Endocannabinoid System as a Novel Therapeutic Target in Epilepsy
Mohammad Moein Vakilzadeh, Amirhossein Heidari, Ali Mehri, Sajad Sahab Negah *
Department of Neuroscience, Mashhad University of Medical Sciences, Mashhad, Iran , sahabsajad@yahoo.com
Abstract:   (1337 Views)

Endocannabinoid (ECB) system plays a vital role in responses to stress. Moreover, ECB and its receptors cause anti-inflammatory, anti-oxidative and neuroprotective effects by modulating neuronal, glial and endothelial cell functions. A number of studies have demonstrated ECB system notably defects in neurotraumatic and neurodegenerative diseases like epilepsy, TBI, Alzheimer’s disease and Parkinson’s disease. ECB system comprise of various compartments, including 2 G-protein-coupled receptors (GCPCRs), named CB1 and CB2 receptors, which create two pathways. Most cannabinoid-based drugs used in treating neurodegenerative disorders affect CB1 pathway. Activating CB2 moderate inflammatory response and stimulate the secretion of anti-inflammatory mediators in microglial cells and astrocytes. CB2 function increased in inflammatory condition in neuronal and endothelial cells, which limit neuroinflammation and blood-brain barrier disruption. In conclusion, involvements of ECB system in neurological disorders make it a suitable therapeutic target. In this review, we discussed the role of CB1 and CB2 receptors in neurodegenerative diseases. CB2 pathway is believed involved in inflammation response, but its relationship with epilepsy remains unclear. Therefore, we suggest surveying the expression of CB2 receptor in an animal model of epilepsy. 

Keywords: Endocannabinoid (ECB), Neurodegenerative diseases, Epilepsy, Neuroinflammation
Full-Text [PDF 208 kb]   (422 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Vakilzadeh M M, Heidari A, Mehri A, Sahab Negah S. P 117: Endocannabinoid System as a Novel Therapeutic Target in Epilepsy. Shefaye Khatam. 2017; 5 (S2) :148-148
URL: http://shefayekhatam.ir/article-1-1304-en.html

Volume 5 - The Spring Supplement of Shefaye Khatam 2 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4219